Jeffrey E. Johnson
Impact in
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Emergency Medicine top 10%
- Appendicitis Diagnosis and Management
Papers in
-
- Appendicitis Diagnosis and Management 6
- Oncology 8
- CAR-T cell therapy research 4
- Cancer Cells and Metastasis 2
- Co-authors
- Xiaojiang Cui (5 shared papers)Armando E. Giuliano (4 shared papers)Frank G. Haluska (2 shared papers)Donna Niedzwiecki (2 shared papers)Ying Qu (4 shared papers)Gary Li (2 shared papers)Kenneth H. Grabstein (2 shared papers)Kurt D. Shanebeck (2 shared papers)
- Journals
- JAMA Surgery (4 papers)Blood (2 papers)Scientific Reports (2 papers)Breast Cancer Research and Treatment (2 papers)Journal of Clinical Microbiology (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Jeffrey E. Johnson
37 papers receiving 650 citations
Peers
Comparison fields: 5 of 80
- Oncology 220
- Emergency Medicine 65
- Radiology, Nuclear Medicine and Imaging 105
- Molecular Biology 323
- Cancer Research 57
Countries citing papers authored by Jeffrey E. Johnson
This map shows the geographic impact of Jeffrey E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey E. Johnson more than expected).
Fields of papers citing papers by Jeffrey E. Johnson
This network shows the impact of papers produced by Jeffrey E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey E. Johnson. The network helps show where Jeffrey E. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 129 | |
| 2 | 2015 | 128 | |
| 3 | 2012 | 63 | |
| 4 | 2016 | 34 | |
| 5 | 2022 | 31 | |
| 6 | 2017 | 30 | |
| 7 | 2016 | 29 | |
| 8 | 2017 | 26 | |
| 9 | 2022 | 22 | |
| 10 | 1996 | 19 | |
| 11 | 2005 | 18 | |
| 12 | 2015 | 16 | |
| 13 | 2016 | 14 | |
| 14 | 2025 | 11 | |
| 15 | 2017 | 10 | |
| 16 | 2022 | 9 | |
| 17 | 1996 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2021 | 8 | |
| 20 | 2023 | 7 |
About Jeffrey E. Johnson
Jeffrey E. Johnson is a scholar working on Emergency Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 38 papers that have together received 684 indexed citations. Recurring topics across this work include Appendicitis Diagnosis and Management (6 papers), CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Genomics and Chromatin Dynamics (3 papers), Breast Cancer Treatment Studies (2 papers), Cancer Cells and Metastasis (2 papers), FOXO transcription factor regulation (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (220 citations), Emergency Medicine (65 citations), Radiology, Nuclear Medicine and Imaging (105 citations), Molecular Biology (323 citations) and Cancer Research (57 citations). Jeffrey E. Johnson has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Xiaojiang Cui, Armando E. Giuliano, Frank G. Haluska, Donna Niedzwiecki, Ying Qu, Gary Li, Kenneth H. Grabstein, Kurt D. Shanebeck, Marcello Marelli and Hengyu Xu. Their work appears in journals such as JAMA Surgery, Blood, Scientific Reports, Breast Cancer Research and Treatment and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.